Recent Articles

12 Pharmaceuticals Stocks to Sell Now

This week, 12 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Vivus, Inc.: Don’t Overthink This Bullish Move in VVUS

Surprise! Vivus stock has been one of the market's hottest names since September. Maybe we should trust the guy making it happen. More 

5 Best Stocks Under $5 This Week

Envivio, Vivus, Medovex, One Group Hospitality and VolitionRX were among a number of cheap stocks that charged significantly higher this week. More 

Vivus, Inc. (VVUS): Earnings Preview

The VIVUS earnings report coming on Monday could be a harsh reality check about the long-term prospects for Qsymia. More 

Orexigen (OREX) Stock Shoots Higher as Contrave Goes on Sale

Orexigen's Contrave joined a couple other FDA-approved weight-loss treatments on the market ... and the OREX product is a serious player. More 

20 Cheap Stocks Under $10 Worth Zilch

Cheap stocks under $10 are tempting because of their low share price, but some picks are cheap for a reason. Avoid these "bargain" stocks! More 

Mannkind (MNKD) – Right Stock, Wrong Time

Ten years' worth of work from Mannkind Corporation on Afrezza has just been validated, but that doesn't automatically make the stock a good bet right here, and right now. More